Related references
Note: Only part of the references are listed.Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
Rita D. Brandao et al.
BREAST CANCER RESEARCH (2013)
Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes
Byeong-Woo Park et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence
Xuehong Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue
Mohammad A. Mohammad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
Michelle D. Holmes et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer-025EFcomparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial
M. Schmidt et al.
ANNALS OF ONCOLOGY (2009)
Estradiol Stimulates Vasodilatory and Metabolic Pathways in Cultured Human Endothelial Cells
Agua Sobrino et al.
PLOS ONE (2009)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation
Bruce G. Haffty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib
Luc Yves Dirix et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Reduced expression of cyclooxygenase-2 in primary breast cancer
Eva-Maria Boneberg et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
Bahi Takkouche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer
K. McCarthy et al.
EJSO (2006)
Cyclooxygenase-2 expression in postmastectomy chest wall relapse
JH Kim et al.
CLINICAL CANCER RESEARCH (2005)
Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma
L Nakopoulou et al.
PATHOBIOLOGY (2005)
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
GP Boland et al.
BRITISH JOURNAL OF CANCER (2004)
Analysis of cyclooxygenase-2 expression in human breast cancer:: high throughput tissue microarray analysis
P Wülfing et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma
C Denkert et al.
CANCER (2003)
Correlation of COX-2 and Fp-CAM overexpression in human invasive breast cancer and its impact on survival
G Spizzo et al.
BRITISH JOURNAL OF CANCER (2003)
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
C Costa et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Cyclooxygenase-5: a target for the prevention and treatment of breast cancer
LR Howe et al.
ENDOCRINE-RELATED CANCER (2001)
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
CH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
